Abstract
Chagas disease, caused by the parasite Trypanosoma cruzi, is considered endemic in more than 20 countries but lacks both an approved vaccine and limited treatment for its chronic stage. Chronic infection is most harmful to human health because of long-term parasitic infection of the heart. Here we show that immunization with a virus-like particle vaccine displaying a high density of the immunogenic α-Gal trisaccharide (Qβ-αGal) induced several beneficial effects concerning acute and chronic T. cruzi infection in α1,3-galactosyltransferase knockout mice. Approximately 60% of these animals were protected from initial infection with high parasite loads. Vaccinated animals also produced high anti-αGal IgG antibody titers, improved IFN-γ and IL-12 cytokine production, and controlled parasitemia in the acute phase at 8 days post-infection (dpi) for the Y strain and 22 dpi for the Colombian strain. In the chronic stage of infection (36 and 190 dpi, respectively), all of the vaccinated group survived, showing significantly decreased heart inflammation and clearance of amastigote nests from the heart tissue.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
national institute of health
national institute of science and technology for vaccines
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference87 articles.
1. The discovery of Trypanosoma cruzi and Chagas disease (1908–1909): tropical medicine in Brazil;SP Kropf;Hist Cienc Saude Manguinhos,2009
2. Chagas disease;A Rassi;Lancet,2010
3. Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA;MS Nolan;Emerg Infect Dis,2021
4. Chagas disease in Latin America: an epidemiological update based on 2010 estimates;Wkly Epidemiol Rec,2015
5. The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease;LH Malik;Clin Cardiol,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献